Wendye Robbins, former Blade Therapeutics CEO

Scoop: Blade Ther­a­peu­tics CEO, CFO ap­pear to de­part amid 'tran­si­tion' af­ter nixed SPAC

The two top ex­ec­u­tives at Blade Ther­a­peu­tics ap­pear to no longer be with the biotech af­ter the start­up failed to merge with its SPAC part­ner ear­li­er this year.

The biotech’s CEO and CFO no longer list the San Fran­cis­co-based drug de­vel­op­er as their em­ploy­er on their LinkedIn pages, and oth­er em­ploy­ee pro­files list them­selves as “open to work.” When reached via LinkedIn on Thurs­day, for­mer CEO Wendye Rob­bins said the com­pa­ny is “in the mid­dle of a tran­si­tion.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.